EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy

Liqin Zhu iD, Zhikai Ding, Xingliang Li, Hongyuan Wei, Yue Chen

Molecular Imaging · 01.01.2020 · 19

DOI: 10.1177/1536012120934957 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Imaging, online erschienen am 31.08.2020. Verfasst von Liqin Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, 556508The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, People's Republic of China. Hauptthemen laut MEDLINE: Biomedical Research. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asn-Gly-Arg (NGR) motifs have vasculature-homing properties via interactions with the aminopeptidase N (CD13) expressed on tumor neovasculature. Numerous NGR peptides with different molecular scaffolds have been exploited for targeted delivery of different compounds for imaging and therapy. When conjugated with NGR, complexes recognize the CD13 receptor expressed on the tumor vasculature, which improves the specificity to tumor and avoids systematic toxic reactions. Both preclinical and clinical studies performed with these products suggest that NGR-mediated vascular targeting is an effective strategy for delivering bioactive amounts of cytokines to tumor endothelial cells. For molecular imaging, radiolabeled peptides have been the most successful approach and have been translated into clinic. This review describes current data on radiolabeled tumor vasculature-homing NGR peptides for imaging and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomedical ResearchAnimalsDrug Delivery SystemsHumansMolecular ImagingNeoplasmsOligopeptidesRadiopharmaceuticals

Stichwörter der Autor:innen

NGRimagingradiolabeledtherapytumor

Substanzen

NGR peptideOligopeptidesRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, 556508The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
  • Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan, People's Republic of China.
  • Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, People's Republic of China.

ORCID-Profile: Liqin Zhu

Zitieren

APA

Zhu, L., Ding, Z., Li, X., Wei, H., & Chen, Y. (2020). Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy. Molecular Imaging, 19. https://doi.org/10.1177/1536012120934957

Vancouver

Zhu L, Ding Z, Li X, Wei H, Chen Y. Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy. Molecular Imaging. 2020;19. doi:10.1177/1536012120934957

BibTeX
@article{Zhu2020,
  author = {Zhu, Liqin and Ding, Zhikai and Li, Xingliang and Wei, Hongyuan and Chen, Yue},
  title = {Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy},
  journal = {Molecular Imaging},
  year = {2020},
  volume = {19},
  doi = {10.1177/1536012120934957}
}
Kostenlos starten →